KLK3 and pachyonychia congenita: Wang et al. have shown that the use of a MALAT1 model, which may serve as an independent predictor of PC, would prevent unnecessary biopsies in about 30.2–46.5% of patients with serum PSA levels in the “diagnostic grey zone” (PSA 4–10 ng/mL) [90].